In a randomized , double-blind , placebo-controlled 8-week crossover trial with a 4 week wash-out period , oral supplements of 8.1 mmol of magnesium-pidolate or placebo were administered twice a day to 14 healthy normomagnesemic participants , aged 23-33 years .